Nucleus Software Q2 results disappoint with poor revenue and net profit growth
Nucleus Software Q2 results disappoint with poor revenue and net profit growth

Nucleus Software Q2 results disappoint with poor revenue and net profit growth

Nucleus Software powers the operations of more than 200 Financial Institutions in over 50 countries.

Subramanian K Article rating: 5.0

Q2 result: Revenue delined 18.6 per cent on YoY basis, Net profit declined 248 per cent on YoY bais, company had weak margins in Q2 quarter due to increase in mployee benefit expenses.

These smallcap and midcap stocks staged a smart recovery from days low!
These smallcap and midcap stocks staged a smart recovery from days low!

These smallcap and midcap stocks staged a smart recovery from days low!

Recovery from the lower levels indicates that the market participants actively participated in these stocks at the lower levels.

Rohit Kale Article rating: 3.9

Recovery from the lower levels indicates that the market participants actively participated in these stocks at the lower levels. 

T20 breakout stocks: Best swing trading stocks to keep an eye on!
T20 breakout stocks: Best swing trading stocks to keep an eye on!

T20 breakout stocks: Best swing trading stocks to keep an eye on!

A divergent trend was witnessed in the broader markets with Nifty Midcap 100 ending in green, while Smallcap 100 slipped lower. 

Karan Dsij Article rating: 3.0

But recovery was seen as Nifty staged a comeback of nearly 70 points from day’s low, but once again this pullback was used to lighten their positions. As a result, Nifty ended the day with modest gain. 

Glittering metal: Is gold all set to shine?
Glittering metal: Is gold all set to shine?

Glittering metal: Is gold all set to shine?

Henil Shah Article rating: 4.2

For the last 14 months, Gold has been consolidating southwards. It gave a breakout last week. So, is gold all set to further glitter? Let’s find out.

Biocon: Can this laggard turn into a leader after this path-breaking announcement?
Biocon: Can this laggard turn into a leader after this path-breaking announcement?

Biocon: Can this laggard turn into a leader after this path-breaking announcement?

So, market participants are puzzled by this out of the box up-move witnessed by the stock. What is the reason, let's find out. 

Karan Dsij Article rating: 4.3

So for investors who are holding this stock, the good news is that the stock has moved above the strike price (350) of its highest base open interest on the call option, while on other hand, the highest open interest on the put side base is now shifted at 350 strike price. Sustaining above this level could trigger a good short-covering rally

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The 52-week high refers to the highest market price of a given security over a 52-week (one year) period.

Ninad Ramdasi Article rating: 3.3

Here’s a list of the stocks that are close to their 52-week high.

RSS
First20012002200320042006200820092010Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR